glp-1 agonist and dpp-4 inhibitor Mechanism of action for GIP, analogues DPP4 inhibitors in GLP-1-based therapies, including GLP-1, GLP-1R
Description
US National Libary of Medicine

DPP-4 inhibitors for type 2 diabetes: is one approach more successful or preferable than the other

Hypothalamic AMP-activated protein kinase as a whole-body energy sensor and regulator

Population-based cohort study

JAMA Intern Med 173:534539 Elashoff M, Matveyenko AV, Gier B, Elashoff R, Butler PC (2011) Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies
